Share on StockTwits

VIVUS (NASDAQ:VVUS) saw a significant drop in short interest in the month of July. As of July 31st, there was short interest totalling 37,015,027 shares, a drop of 6.2% from the July 15th total of 39,474,428 shares, ARN reports. Currently, 36.2% of the shares of the stock are sold short. Based on an average trading volume of 1,333,094 shares, the days-to-cover ratio is presently 27.8 days.

Shares of VIVUS (NASDAQ:VVUS) opened at 4.69 on Tuesday. VIVUS has a 52 week low of $4.44 and a 52 week high of $13.74. The stock has a 50-day moving average of $4.88 and a 200-day moving average of $5.53. The company’s market cap is $484.5 million.

VIVUS (NASDAQ:VVUS) last issued its quarterly earnings data on Thursday, August 7th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28) by $0.03. The company had revenue of $21.90 million for the quarter, compared to the consensus estimate of $17.90 million. During the same quarter in the previous year, the company posted ($0.55) earnings per share. The company’s revenue for the quarter was up 298.2% on a year-over-year basis. On average, analysts predict that VIVUS will post $-0.99 earnings per share for the current fiscal year.

VIVUS, Inc is a biopharmaceutical company. It commercializes and develops therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.